Main Line Retirement Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$779K Buy
847
+1
+0.1% +$1.01K 0.39% 26
2025
Q4
$909K Buy
846
+20
+2% +$19.1K 0.46% 23
2025
Q3
$630K Sell
826
-23
-3% -$17.1K 0.32% 26
2025
Q2
$662K Buy
849
+21
+3% +$16.3K 0.38% 25
2025
Q1
$684K Hold
828
0.44% 23
2024
Q4
$639K Hold
828
0.42% 24
2024
Q3
$734K Sell
828
-4
-0.5% -$3.6K 0.5% 20
2024
Q2
$753K Buy
832
+6
+0.7% +$4.8K 0.58% 19
2024
Q1
$643K Hold
826
0.51% 20
2023
Q4
$482K Buy
+826
New +$482K 0.42% 22
2023
Q2
$386K Buy
+824
New +$346K 0.36% 21

Other funds holding LLY

Main Line Retirement Advisors's LLY Position: Q1 2026 in Review

Main Line Retirement Advisors increased its Eli Lilly (LLY) stake by 0.12% in Q1 2026, buying an estimated $1.01K and bringing the position to 847 shares worth $779K. The position accounts for 0.39% of the portfolio, ranked #26.

Main Line Retirement Advisors first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $909K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Main Line Retirement Advisors held 847 shares of Eli Lilly worth $779K as of Q1 2026.
  • Main Line Retirement Advisors bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.39% of Main Line Retirement Advisors's portfolio in Q1 2026, its #26 holding.
  • Main Line Retirement Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • Main Line Retirement Advisors's Eli Lilly position peaked at $909K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Main Line Retirement Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.